By InvitationPhase 1

A Study to Evaluate the Effect of Food on the Pharmacokinetic Characteristics and Safety Profile of AD-117 in Healthy Adult Volunteers

South Korea60 participantsStarted 2026-02

Plain-language summary

Who can participate

Age range19 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Body weight equal to or greater than 50kg (Female 45kg) and Body mass index (BMI) between 18.0 kg/m2 and 30.0 kg/m2 at the time of screening visit * Healthy volunteers aged ≥19 and \<65 years at the time of screening visit Exclusion Criteria: * Participation in another clinical study with an investigational drug within the 6 months from scheduled first administration * Other exclusions applied

What they're measuring

Maximum concentration of drug in plasma (Cmax)

Timeframe: 0-72 hours

Area under the plasma concentration-time curve during dosing interval (AUCt)

Timeframe: 0-72 hours

Trial details

NCT IDNCT07495514

SponsorAddpharma Inc.

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2026-03

View on ClinicalTrials.gov More Mixed Dyslipidemia trials